The Effectiveness of High-dose Intravenous Vitamin c With Very Low Carbohydrate Diet for Terminal Colon Cancer Patients

Last updated: July 26, 2019
Sponsor: National Taiwan University Hospital
Overall Status: Active - Not Recruiting

Phase

1/2

Condition

Colorectal Cancer

Colon Cancer

Treatment

N/A

Clinical Study ID

NCT04035096
201901083MINB
  • Ages > 20
  • All Genders

Study Summary

The purpose is to evaluate the effectiveness of high dose intravenous vitamin C (IVC) therapy plus very low carbohydrate diet (VLCD) for stage IV colon cancer (with KRAS and BRAF mutation ) with or without chemotherapy.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • stage IV colon cancer

  • with KRAS and BRAF mutation

Exclusion

Exclusion Criteria:

  • G-6-PD deficiency,

  • metastatic kidney disease,

  • obstructive uropathy,

  • nephrotic syndrome,

  • under other alternative medicine treatment or intravenous vitamin treatment,

  • pregnant or lactating women,

  • impaired renal function with a serum creatinine ≥ 132.6µmol/L(1.5 mg/dL)

  • significant fluid retention(pleural effusion, ascites, lower leg edema),

  • terminal heart failure,

  • incapability to make decision,

Study Design

Total Participants: 40
Study Start date:
January 01, 2020
Estimated Completion Date:
June 30, 2022

Study Description

High dose IVC induces pro-oxidant effects, inhibits energy metabolism, acts as cytotoxic effect, and induces cancer cell apoptosis and necrosis. The recent advance in Warburg effect makes a new direction in high dose IVC therapy. The Warburg effect is the enhanced conversion of glucose to lactate observed in tumor cells, even in the presence of normal levels of oxygen. Converting glucose to lactate, rather than metabolizing it through oxidative phosphorylation in the mitochondria, is far less efficient as less ATP is generated per unit of glucose metabolized. Therefore, a high rate of glucose uptake is required to meet increased energy needs to support rapid tumor progression..

Vitamin C shares very similar structure with glucose. The high-dose IVC gets accessibility to glucose transporter, with competition to glucose. Having a reduced level of blood sugar seems to be a necessary parameter to increase IVC's anticancer effectiveness. VLCD with high dose IVC showed effectiveness in case series.

The investigator's project is a single-centered, clinical trial (pilot study) for stage IV colon cancer patients with or without chemotherapy. The experimental group will receive high dose vitamin C 75 or 100g (with blood vitamin C level > 350 mg/dl) in 1000 ml distilled water in 2-hour infusion, twice per week for 12 weeks. Then maintenance dose is 75-100 g once per 2 weeks for 12 weeks. Very low carbohydrate diet will be executed for the first 12 weeks. The control group will be matched for age, sex and chemotherapy and target therapy medication. The control group will receive usual care. The primary outcome will be the response rate by computerized tomography (CT) of the chest, abdomen and pelvis at 12 weeks and 24 weeks. The secondary outcome will be the improvement of tumor markers (CEA and Ca199).

This is the first clinical trial of IVC therapy with VLCD for stage IV colon cancer in Taiwan and in the world. This innovation will give us a primitive answer on the effectiveness of IVC therapy with VLCD for cancers. Vitamin C is a cheap and harmless therapy. The study result will open a door for alternative cancer treatment.

Connect with a study center

  • National Taiwan University Hospital

    Taipei, 100
    Taiwan

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.